InvestSMART

Radiopharm Theranostics Limited (ASX: RAD) - Announcements

Current share price for RAD : $0.011 0.001 (8.33%)+

ASX company news and announcements for Radiopharm Theranostics Limited (RAD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Radiopharm Theranostics Limited (RAD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Radiopharm Theranostics Limited (RAD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Radiopharm Theranostics Limited (RAD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$48 RAD Initial Findings from Phase 1 177Lu-RAD202 Trial 20 Apr 2026 8:54AM $0.021 $0.011 fallen by 46.34%
$48 RAD Completes Enrollment in Phase 2b Trial of RAD 101 16 Apr 2026 8:41AM $0.021 $0.011 fallen by 47.62%
$48 RAD202 Phase 1 HEAT Trial Advances to Dose Level 3 8 Apr 2026 9:00AM $0.020 $0.011 fallen by 45%
$48 RAD and Siemens Sign Clinical Supply Agreement for RAD101 7 Apr 2026 8:31AM $0.021 $0.011 fallen by 47.62%
$48 Change of Director's Interest Notice (IT) 31 Mar 2026 3:53PM $0.021 $0.011 fallen by 46.34%
$48 RAD Doses First Patient in RAD 402 Phase 1 Clinical Study 27 Mar 2026 8:23AM $0.020 $0.011 fallen by 45%
$48 RAD101 2nd interim Ph.2b data - 90% achieve primary endpoint 24 Mar 2026 9:34AM $0.020 $0.011 fallen by 45%
$48 RAD to present at NWR Virtual Healthcare Conference 19 Mar 2026 10:08AM $0.021 $0.011 fallen by 47.62%
$48 Half Year Report and Appendix 4D 31 December 2025 27 Feb 2026 1:03PM $0.022 $0.011 fallen by 50%
$48 RAD Doses First Patient in 177Lu-BetaBart (RV-01) Study 24 Feb 2026 9:25AM $0.022 $0.011 fallen by 50%
$48 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jan 2026 9:19AM $0.023 $0.011 fallen by 52.17%
$48 RAD Increases Ownership in Radiopharm Ventures to 87.5% 12 Jan 2026 8:27AM $0.025 $0.011 fallen by 56%
$48 Change in substantial holding 7 Jan 2026 10:58AM $0.023 $0.011 fallen by 52.17%
$48 Notification of cessation of securities - RAD 23 Dec 2025 10:27AM $0.025 $0.011 fallen by 56%
$48 Change of Director's Interest Notice (RC) 19 Dec 2025 5:29PM $0.026 $0.011 fallen by 57.69%
$48 Change of Director's Interest Notice (PH) 19 Dec 2025 5:28PM $0.026 $0.011 fallen by 57.69%
$48 Change of Director's Interest Notice (IT) 19 Dec 2025 5:26PM $0.026 $0.011 fallen by 57.69%
$48 Notification regarding unquoted securities - RAD 19 Dec 2025 5:11PM $0.026 $0.011 fallen by 57.69%
$48 Proposed issue of securities - RAD 18 Dec 2025 3:07PM $0.027 $0.011 fallen by 59.26%
$48 RAD announces establishment of At-The-Market Equity Facility 18 Dec 2025 2:42PM $0.027 $0.011 fallen by 59.26%
$48 Non-compliance with ASX Listing Rule 7.1 18 Dec 2025 2:22PM $0.027 $0.011 fallen by 59.26%
$48 RAD101 interim Phase 2b data - 92% achieve primary endpoint 15 Dec 2025 9:35AM $0.019 $0.011 fallen by 42.11%
$48 Ceasing to be a substantial holder PH 10 Dec 2025 10:26AM $0.019 $0.011 fallen by 42.11%
$48 Notice Under Section 708A 9 Dec 2025 11:09AM $0.020 $0.011 fallen by 43.59%
$48 Application for quotation of securities - RAD 9 Dec 2025 10:51AM $0.019 $0.011 fallen by 42.11%

26 - 50 of 610 results

Page 2 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.